A new way to access a woman’s fibroids to nonsurgically shrink noncancerous growths in the muscular wall of the uterus has been developed by interventional radiologists, according to a report published in the March issue of the Journal of Vascular and Interventional Radiology. 

International medical imaging IT company, Sectra  (STO: SECT B), and IDS announce Sectra CloudFlex, a cloud-based, comprehensive suite of breast imaging tools designed for low-volume mammography sites.

Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, will showcase its extensive portfolio of innovative products for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment, and extremity imaging at the annual meeting of the European Society of Radiology, in Vienna, Austria March 6th through 10th. 

An EDGE™ point-of-care ultrasound system from FUJIFILM SonoSite is helping the Medical Services team at Harlequin FC rugby club to diagnose and monitor musculoskeletal injuries, providing valuable information to aid the treatment and rehabilitation of players.

Tomosynthesis is superior to radiography and almost comparable to MRI of the wrist and hand in the detection of bone erosion in patients with rheumatoid arthritis (RA), according to a study published in the February issue of the American Journal of Roentgenology. 

An extended follow up of the Canadian National Breast Screening Study (CNBSS) found that annual mammography does not reduce breast cancer mortality for women aged 40-59 beyond what is achieved with usual care and physical examination, according to results published Feb. 11 in the British Medical Journal (BMJ).

Physicians may be able to more accurately select treatments that will target genomic alterations in women with advanced breast cancer, according to a study published online Feb. 7 by The Lancet Oncology. The study’s findings could also aid in clinical trial design and drug development. 

The American Society for Radiation Oncology (ASTRO) and the Society of Surgical Oncology (SSO) have published a consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.